Page last updated: 2024-12-05

cumene hydroperoxide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Cumene hydroperoxide (CHP) is an organic peroxide compound with the formula C6H5C(CH3)2OOH. It is a colorless liquid that is important in the production of phenol and acetone through the cumene process. CHP is synthesized by the autoxidation of cumene (isopropylbenzene) in the presence of oxygen. It is a highly reactive compound and can be explosive under certain conditions. CHP is studied extensively due to its role in the cumene process, a major industrial process for the production of phenol and acetone. It is also used as an initiator in polymerization reactions and as an oxidizer in various chemical reactions. CHP is a key intermediate in the production of phenol and acetone, which are valuable chemicals used in numerous industrial applications.'

cumene hydroperoxide: RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

cumene hydroperoxide : A peroxol that is cumene in which the alpha-hydrogen is replaced by a hydroperoxy group. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID6629
CHEMBL ID1518369
CHEBI ID78673
SCHEMBL ID15251
SCHEMBL ID11210695
MeSH IDM0050177

Synonyms (94)

Synonym
AKOS015841738
hydroperoxide, .alpha.,.alpha.-dimethylbenzyl
hydroperoxide, 1-methyl-1-phenylethyl
1-methyl-1-phenylethyl hydroperoxide
80-15-9
cumene hydroperoxide
NCGC00091748-01
kumenylhydroperoxid [czech]
ccris 3801
hydroperoxide, alpha,alpha-dimethylbenzyl-
cumolhydroperoxide
cumenyl hydroperoxide
einecs 201-254-7
7-hydroperoxykumen [czech]
idroperossido di cumene [italian]
cumolhydroperoxid [german]
brn 1908117
hydroperoxide de cumene
cumeenhydroperoxyde [dutch]
idroperossido di cumolo [italian]
hydroperoxyde de cumene [french]
rcra waste no. u096
rcra waste number u096
hydroperoxyde de cumyle [french]
cumyl hydroperoxide
hsdb 254
alpha,alpha-dimethylbenzylhydroperoxide
hydroperoxide, alpha,alpha-dimethylbenzyl
isopropylbenzene hydroperoxide
7-cumyl hydroperoxide
alpha,alpha-dimethylbenzyl hydroperoxide
cument hydroperoxide
hydroperoxide, 1-methyl-1-phenylethyl-
cumene hydroperoxide, technical grade, 80%
NCGC00091748-02
cumylhydroperoxide
isopropyl benzene hydroperoxide
C2223
r 239a
2-hydroperoxypropan-2-ylbenzene
chebi:78673 ,
CHEMBL1518369
NCGC00091748-03
dtxsid3024869 ,
dtxcid404869
cas-80-15-9
tox21_300283
NCGC00254045-01
hydroperoxyde de cumene
7-hydroperoxykumen
ph 80
4-06-00-03221 (beilstein handbook reference)
cumeenhydroperoxyde
unii-pg7jd54x4i
pg7jd54x4i ,
idroperossido di cumolo
cumolhydroperoxid
idroperossido di cumene
ec 201-254-7
kumenylhydroperoxid
hydroperoxyde de cumyle
luperox cu 80
trigonox k 90
percumyl h
.alpha.,.alpha.-dimethylbenzyl hydroperoxide
cumene hydroperoxide [hsdb]
CCG-207896
SCHEMBL15251
alpha-cumyl hydroperoxide
alpha-cumene hydroperoxide
cumyl-hydroperoxide
SCHEMBL11210695
hyperiz
.alpha.-cumene hydroperoxide
trigonox k 80
chp-158
trigonox r 239a
trigonox k-95
chp-5
un 2116
.alpha.-cumyl hydroperoxide
2-phenylpropan-2-yl hydroperoxide
STL453641
mfcd00002129
cumene hydroperoxide, technical, ~80% in cumene
2-phenylpropane-2-peroxol
Q414439
cumene hydroperoxide (80per cent, technical grade)
alpha, alpha-dimethylbenzyl hydroperoxide
dimethylbenzyl hydroperoxide
alpha,alpha-dimethylbenzene hydroperoxide
trigonox r 239r
2-phenyl-2-propyl hydroperoxide
kayacumene h

Research Excerpts

Overview

Cumene hydroperoxide (CHP) is a high production volume chemical. It is used to generate phenol and acetone.

ExcerptReferenceRelevance
"Cumene hydroperoxide (CHP) is a high production volume chemical that is used to generate phenol and acetone. "( Dermal Exposure to Cumene Hydroperoxide: Assessing Its Toxic Relevance and Oxidant Potential.
Chan, P; Fomby, LM; Hejtmancik, MR; Herbert, RA; Kadiiska, MB; Kissling, GE; Rider, CV; Travlos, GS; Waidyanatha, S; Witt, KL, 2016
)
2.21

Effects

Cumene hydroperoxide (CHP) has been used in producing phenol, dicumyl peroxide (DCPO) and as an initiator for synthesizing acrylonitrile-butadiene-styrene (ABS) resin by copolymerization. Cumene Hydroperoxide has been proposed to support only the activity of cytochrome P450IID6.

ExcerptReferenceRelevance
"Cumene hydroperoxide (CHP) has been used in producing phenol, dicumyl peroxide (DCPO) and as an initiator for synthesizing acrylonitrile-butadiene-styrene (ABS) resin by copolymerization in Taiwan. "( Calorimetric studies and lessons on fires and explosions of a chemical plant producing CHP and DCPO.
Duh, YS; Hsu, JM; Huang, CY; Su, MS, 2012
)
1.82
"3. Cumene hydroperoxide has been proposed to support only the activity of cytochrome P450IID6."( Propranolol oxidation by human liver microsomes--the use of cumene hydroperoxide to probe isoenzyme specificity and regio- and stereoselectivity.
Gillam, EM; Lennard, MS; Otton, SV; Tucker, GT; Woods, HF, 1990
)
1.04

Treatment

Cumene hydroperoxide treatment (30 mg per animal) increased cutaneous microsomal lipid peroxidation and induction of xanthine oxidase activity. Reduction in the activities of cutaneous antioxidant enzymes and depletion in the level of glutathione.

ExcerptReferenceRelevance
"Cumene hydroperoxide treatment (30 mg per animal) increased cutaneous microsomal lipid peroxidation and induction of xanthine oxidase activity which are accompanied by decrease in the activities of cutaneous antioxidant enzymes and depletion in the level of glutathione."( Modulation of biochemical parameters by Hemidesmus indicus in cumene hydroperoxide-induced murine skin: possible role in protection against free radicals-induced cutaneous oxidative stress and tumor promotion.
Alam, A; Khan, N; Sharma, S; Sultana, S, 2003
)
1.28
"Cumene hydroperoxide treatment at a dose level of 30 mg/animal/0.2 ml acetone enhances susceptibility of cutaneous microsomal membrane for iron-ascorbate-induced lipid peroxidation and induction of xanthine oxidase activity which are accompanied by decrease in the activities of cutaneous antioxidant enzymes such as catalase, glutathione peroxidase, glutathione reductase, glucose-6-phosphate dehydrogenase and depletion in the level of cutaneous glutathione."( Myrica nagi attenuates cumene hydroperoxide-induced cutaneous oxidative stress and toxicity in Swiss albino mice.
Ahmed, S; Alam, A; Iqbal, M; Saleem, M; Sultana, S, 2000
)
1.34
"Cumene hydroperoxide treatment was found to induce lipid peroxidation in both myocytes and lymphocytes, the process being more pronounced in myocytes."( Influence of lipid peroxidation and hydrogen peroxide on muscarinic cholinergic receptors and ATP level in rat myocytes and lymphocytes.
Gajewski, M; Laskowska-Bozek, H; Maśliński, S; Orlewski, P; Ryzewski, J, 1988
)
1
"Treatment with cumene hydroperoxide between 0.66 and 20 microM did not produce a significant modification of cell viability in melanocytes from normal individuals."( Increased sensitivity to peroxidizing agents is correlated with an imbalance of antioxidants in normal melanocytes from melanoma patients.
Biondo, L; Catricalà, C; Grammatico, P; Maresca, V; Picardo, M; Roccella, F; Roccella, M, 1998
)
0.64

Toxicity

ExcerptReferenceRelevance
" MLO was found to be three times more toxic than CumOOH."( Comparative study on the toxicity of methyl linoleate-9,10-ozonide and cumene hydroperoxide to alveolar macrophages.
de Vries, J; Grooten, HN; Hempenius, RA; Rietjens, IM, 1992
)
0.52
"Biliary epithelial cells (BEC) and parenchymal cells isolated from normal rat liver were exposed in vitro to a number of toxic compounds."( Menadione and cumene hydroperoxide induced cytotoxicity in biliary epithelial cells isolated from rat liver.
Biocca, ME; Cheeseman, KH; Dianzani, MU; Parola, M; Slater, TF, 1990
)
0.64
" Acetaminophen appeared to be less toxic to selenium-deficient hepatocytes than to controls."( Toxicity studies in isolated hepatocytes from selenium-deficient rats and vitamin E-deficient rats.
Burk, RF; Hill, KE, 1984
)
0.27
" The results of these tests on the samples collected during the thermal decomposition of the two studied species indicate that in the case of ethyl parathion the decomposition process gives rise to a mixture of compounds which are more toxic than the parent species."( Toxicity of unwanted intermediates and products formed during accidental thermal decomposition of chemicals.
Andreozzi, R; Di Somma, I; Pinto, G; Pollio, A; Sanchirico, R, 2008
)
0.35

Bioavailability

ExcerptReferenceRelevance
" Our data indicated that liposomal quercetin can significantly improve the solubility and bioavailability of quercetin and can be used as an effective antioxidant for ROS protection within the polar cytoplasm, and the nano-sized quercetin encapsulated by liposomes enhanced the cellular uptake (cancer cell human MCF_7)."( Intracellular ROS protection efficiency and free radical-scavenging activity of quercetin and quercetin-encapsulated liposomes.
Barzegar, A; Eidi, A; Rezaei-Sadabady, R; Zarghami, N, 2016
)
0.43

Dosage Studied

ExcerptRelevanceReference
" The dose-response curve of inactivation of transport or of metabolic function varied with the ROS generator used and conformed to one of two patterns of toxicity: either threshold-dependent or single-hit inactivation."( Localization of damage induced by reactive oxygen species in cultured cells.
Buxser, SE; Decker, DE; Vroegop, SM, 1995
)
0.29
" Elevating the gene dosage of GRX1 or GRX2 increases resistance to hydroperoxides including hydrogen peroxide, tert-butyl hydroperoxide and cumene hydroperoxide."( The yeast glutaredoxins are active as glutathione peroxidases.
Avery, AM; Avery, SV; Collinson, EJ; Garrido, EO; Grant, CM; Wheeler, GL, 2002
)
0.52
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (3)

RoleDescription
oxidising agentA substance that removes electrons from another reactant in a redox reaction.
environmental contaminantAny minor or unwanted substance introduced into the environment that can have undesired effects.
Mycoplasma genitalium metaboliteAny bacterial metabolite produced during a metabolic reaction in Mycoplasma genitalium.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
peroxolMonosubstitution products of hydrogen peroxide HOOH, having the skeleton ROOH, in which R is any organyl group.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (16)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
15-lipoxygenase, partialHomo sapiens (human)Potency0.12590.012610.691788.5700AID887
RAR-related orphan receptor gammaMus musculus (house mouse)Potency68.58960.006038.004119,952.5996AID1159521; AID1159523
GLI family zinc finger 3Homo sapiens (human)Potency25.49570.000714.592883.7951AID1259369; AID1259392
AR proteinHomo sapiens (human)Potency13.02860.000221.22318,912.5098AID743063
aldehyde dehydrogenase 1 family, member A1Homo sapiens (human)Potency39.81070.011212.4002100.0000AID1030
nuclear receptor subfamily 1, group I, member 3Homo sapiens (human)Potency45.91740.001022.650876.6163AID1224838; AID1224893
estrogen nuclear receptor alphaHomo sapiens (human)Potency12.58930.000229.305416,493.5996AID588514
vitamin D (1,25- dihydroxyvitamin D3) receptorHomo sapiens (human)Potency41.28090.023723.228263.5986AID588541; AID588543; AID743223
thyroid stimulating hormone receptorHomo sapiens (human)Potency40.10890.001628.015177.1139AID1224843; AID1224895
activating transcription factor 6Homo sapiens (human)Potency61.64480.143427.612159.8106AID1159516
Histone H2A.xCricetulus griseus (Chinese hamster)Potency44.98780.039147.5451146.8240AID1224845
thyroid hormone receptor beta isoform 2Rattus norvegicus (Norway rat)Potency66.67120.000323.4451159.6830AID743065; AID743067
heat shock protein beta-1Homo sapiens (human)Potency57.13250.042027.378961.6448AID743210; AID743228
nuclear factor erythroid 2-related factor 2 isoform 1Homo sapiens (human)Potency45.78920.000627.21521,122.0200AID651741; AID743202; AID743219
nuclear receptor ROR-gamma isoform 1Mus musculus (house mouse)Potency35.48130.00798.23321,122.0200AID2546
Nuclear receptor ROR-gammaHomo sapiens (human)Potency42.16320.026622.448266.8242AID651802
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (13)

Processvia Protein(s)Taxonomy
negative regulation of transcription by RNA polymerase IINuclear receptor ROR-gammaHomo sapiens (human)
xenobiotic metabolic processNuclear receptor ROR-gammaHomo sapiens (human)
regulation of glucose metabolic processNuclear receptor ROR-gammaHomo sapiens (human)
regulation of steroid metabolic processNuclear receptor ROR-gammaHomo sapiens (human)
intracellular receptor signaling pathwayNuclear receptor ROR-gammaHomo sapiens (human)
circadian regulation of gene expressionNuclear receptor ROR-gammaHomo sapiens (human)
cellular response to sterolNuclear receptor ROR-gammaHomo sapiens (human)
positive regulation of circadian rhythmNuclear receptor ROR-gammaHomo sapiens (human)
regulation of fat cell differentiationNuclear receptor ROR-gammaHomo sapiens (human)
positive regulation of DNA-templated transcriptionNuclear receptor ROR-gammaHomo sapiens (human)
adipose tissue developmentNuclear receptor ROR-gammaHomo sapiens (human)
T-helper 17 cell differentiationNuclear receptor ROR-gammaHomo sapiens (human)
regulation of transcription by RNA polymerase IINuclear receptor ROR-gammaHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (10)

Processvia Protein(s)Taxonomy
RNA polymerase II cis-regulatory region sequence-specific DNA bindingNuclear receptor ROR-gammaHomo sapiens (human)
DNA-binding transcription factor activity, RNA polymerase II-specificNuclear receptor ROR-gammaHomo sapiens (human)
DNA-binding transcription repressor activity, RNA polymerase II-specificNuclear receptor ROR-gammaHomo sapiens (human)
DNA-binding transcription factor activityNuclear receptor ROR-gammaHomo sapiens (human)
protein bindingNuclear receptor ROR-gammaHomo sapiens (human)
oxysterol bindingNuclear receptor ROR-gammaHomo sapiens (human)
zinc ion bindingNuclear receptor ROR-gammaHomo sapiens (human)
ligand-activated transcription factor activityNuclear receptor ROR-gammaHomo sapiens (human)
sequence-specific double-stranded DNA bindingNuclear receptor ROR-gammaHomo sapiens (human)
nuclear receptor activityNuclear receptor ROR-gammaHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (4)

Processvia Protein(s)Taxonomy
nucleusNuclear receptor ROR-gammaHomo sapiens (human)
nucleoplasmNuclear receptor ROR-gammaHomo sapiens (human)
nuclear bodyNuclear receptor ROR-gammaHomo sapiens (human)
chromatinNuclear receptor ROR-gammaHomo sapiens (human)
nucleusNuclear receptor ROR-gammaHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID638017Cytotoxicity against human SH-SY5Y cells assessed as cell viability at 300 uM by MTT assay2012Bioorganic & medicinal chemistry letters, Jan-01, Volume: 22, Issue:1
An expedient synthesis of honokiol and its analogues as potential neuropreventive agents.
AID624687Mechanism based inhibition of rat cytochrome P450 CYP2B12005Current drug metabolism, Oct, Volume: 6, Issue:5
Cytochrome p450 enzymes mechanism based inhibitors: common sub-structures and reactivity.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (599)

TimeframeStudies, This Drug (%)All Drugs %
pre-1990135 (22.54)18.7374
1990's229 (38.23)18.2507
2000's157 (26.21)29.6817
2010's73 (12.19)24.3611
2020's5 (0.83)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 61.70

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index61.70 (24.57)
Research Supply Index6.43 (2.92)
Research Growth Index4.46 (4.65)
Search Engine Demand Index105.26 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (61.70)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (0.16%)5.53%
Reviews3 (0.48%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other615 (99.35%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]